MARKET

UPB

UPB

UpStream Bio Inc.
NASDAQ
26.20
+0.20
+0.77%
After Hours: 26.25 +0.05 +0.19% 19:55 02/06 EST
OPEN
26.56
PREV CLOSE
26.00
HIGH
27.98
LOW
25.94
VOLUME
517.91K
TURNOVER
--
52 WEEK HIGH
33.68
52 WEEK LOW
5.14
MARKET CAP
1.42B
P/E (TTM)
-11.3809
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on These Healthcare Stocks: Evolus (EOLS), Upstream Bio, Inc. (UPB)
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: DaVita (DVA), Upstream Bio, Inc. (UPB) and ACADIA Pharmaceuticals (ACAD)
TipRanks · 4d ago
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB), Kymera Therapeutics (KYMR) and ACADIA Pharmaceuticals (ACAD)
TipRanks · 4d ago
Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Twist Bioscience (TWST)
TipRanks · 4d ago
Weekly Report: what happened at UPB last week (0126-0130)?
Weekly Report · 5d ago
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and BillionToOne, Inc. Class A (BLLN)
TipRanks · 01/30 13:21
Analysts’ Top Healthcare Picks: Regeneron (REGN), Resmed (RMD)
TipRanks · 01/30 13:01
Notable Wednesday Option Activity: AAOI, PNTG, UPB
NASDAQ · 01/28 20:20
More
About UPB
Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist in clinical development, that targets the receptor for thymic stromal lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. It has advanced this highly potent monoclonal antibody into separate phase II trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps and plans to initiate development in chronic obstructive pulmonary disease. TSLP is a member of a class of epithelial cytokines, also including IL-25 and IL-33, commonly referred to as alarmins. TSLP is primarily produced by epithelial cells, especially in the lung, gastrointestinal tract and skin.

Webull offers UpStream Bio Inc. stock information, including NASDAQ: UPB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UPB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UPB stock methods without spending real money on the virtual paper trading platform.